Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 50 years and ≤ 75 years~* Life expectancy \>10 years~* Localized prostatic adenocarcinoma and histologically proven~* Intermediate risk cancer(T2b or PSA between 10 and 20 or Gleason = 7(3+4) according to Amico criteria~* Metastasis or pelvic pathologic ganglion (≥ 10 mm) absence~* OMS \< 2~* No previous treatment by radiotherapy and/or curietherapy~* Hormonotherapy authorized before and during the study~* Rectal or uretero-vesical pathology~* Signed informed consent~* Social security system affiliation~* Individual deprived of liberty or placed under the authority of a tutor.~* No anesthesia contraindication~Exclusion Criteria:~* Adenocarcinoma not histologically proven~* Metastases presence~* Pathological nodes presence(≥ 10 mm)~* Prior prostate endoscopic resection~* history of other malignancy except for appropriately treated superficial basal cell skin cancer~* Medical contraindications to anesthesia~* Patients with uncontrolled psychiatric disease or medical disease incompatible with the protocol~* Impossibility to respect the medical follow-up of the protocol for geographical, social or psychic reasons

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).